| 1. | | Recruiting | Phase 1 Study of BL22 to Treat Acute Lymphocytic Leukemia or Non-Hodgkin's Lymphoma in Children and Young Adults
Conditions: Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Acute |
| 2. | | Recruiting | Phase 3 BBR 2778 for Relapsed, Aggressive Non-Hodgkin’s Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin |
| 3. | | Recruiting | Selective T-Cell Depletion to Reduce Graft-Versus-Host-Disease in Patients Receiving Stem Cell Transplantation to Treat Leukemia, Lymphoma or Myelodysplastic Syndromes
Conditions: Graft vs Host Disease; Myelodysplastic Syndromes; Leukemia; Leukemia, Myeloid; Leukemia, Myelomonocytic, chronic; Leukemia, Lymphocytyc; Lymphoma; ... |
| 4. | | Recruiting | Meaning-Centered Psychotherapy in Advanced Cancer
Conditions: Lymphoma, Non-Hodgkin; Neoplasms |
| 5. | | Recruiting | A Phase II Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects with Refractory Lymphoma
Conditions: Lymphoma, Non-Hodgkin; Hodgkin's Lymphoma |
| 6. | | Recruiting | Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 7. | | Not yet recruiting | Rituximab and Fludarabine Followed by Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 8. | | Recruiting | Bendamustine in Treating Patients With Rituximab-Refractory Indolent B-Cell Non-Hodgkin’s Lymphoma
Conditions: adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma |
| 9. | | Recruiting | CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 10. | | Recruiting | Tipifarnib in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma; ... |
| 11. | | Recruiting | Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Conditions: adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma; refractory plasma cell neoplasm |
| 12. | | Recruiting | Bortezomib and Fludarabine in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 13. | | Recruiting | Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 14. | | Recruiting | Monoclonal Antibody Therapy in Treating Patients With Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
Conditions: AIDS-related peripheral and systemic lymphoma; adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; ... |
| 15. | | Recruiting | Bortezomib in Treating Patients With Lymphoproliferative Disorders
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 16. | | Recruiting | Monoclonal Antibody Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma |
| 17. | | Recruiting | Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma; Prolymphocytic Leukemia; ... |
| 18. | | Recruiting | Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 19. | | Recruiting | Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
Conditions: Lymphoma; Non-Hodgkin's Lymphoma |
| 20. | | Recruiting | Rituximab plus CAMPATH in Patients with Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL
Condition: Non-Hodgkin's Lymphoma |
| 21. | | Recruiting | SDX-105 in Combination with Rituxan for Patients with Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
Condition: Non-Hodgkin's Lymphoma |
| 22. | | Recruiting | Pharmacokinetic Study of Previously Untreated, Relapsed, or Transformed Follicular Non-Hodgkin's Lymphoma with Fission-Derived Iodine I 131 Tositumomab
Condition: Non-Hodgkin's Lymphoma |
| 23. | | Recruiting | Phase I/II Study of CAMPATH in Patients with Relapsing or Refractory Non-Hodgkin’s Lymphoma
Condition: Non-Hodgkins Lymphoma |
| 24. | | Recruiting | Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia |
| 25. | | Recruiting | Phase I/II Study of Tac-Expressing Malignancies [Other than Adult T-Cell Leukemia (ATL)] with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA
Conditions: Cutaneous T Cell Lymphoma; Hodgkin's Disease; Neoplasm; Non Hodgkin's Lymphoma; Peripheral T Cell Lymphoma |
| 26. | | Recruiting | Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients with Follicular Lymphoma
Condition: Non-Hodgkins Lymphoma |
| 27. | | Recruiting | Safety and Activity of SDX-105 (Bendamustine) in Patients with Rituximab Refractory Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma |
| 28. | | Recruiting | Study of TRM-1 (TRAIL-R1 monoclonal antibody) in Subjects with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin |
| 29. | | Recruiting | Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin’s Lymphoma
Conditions: Leukemia; Lymphoma, Non-Hodgkin |
| 30. | | Recruiting | Double Cord Blood Transplant Study
Conditions: Leukemia, Lymphocytic, Acute; Leukemia, Myelocytic, Acute; Leukemia, Myeloid, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma |
| 31. | | Recruiting | A Phase 1 Study of CMC-544 Administered as a Single Agent in Subjects With B-Cell Non-Hodgkin’s Lymphoma
Conditions: Lymphoma, Non-Hodgkin's; B-Cell Lymphoma |
| 32. | | Recruiting | Chemotherapy for Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Solid Malignancies; Non-Hodgkin's Lymphoma |
| 33. | | Recruiting | Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin’s Lymphoma
Condition: Non-Hodgkin's Lymphoma |
| 34. | | Not yet recruiting | BCX-1777 in Treating Patients With Recurrent or Refractory Advanced T-Cell Leukemia or T-Cell Lymphoma
Conditions: acute leukemia; adult T-cell leukemia and lymphoma; childhood lymphoblastic lymphoma; Non-Hodgkin's Lymphoma; Prolymphocytic Leukemia |
| 35. | | Not yet recruiting | Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease; Non-Hodgkin's Lymphoma; ... |
| 36. | | Recruiting | Xcellerated T CellsTM for Non-Hodgkin’s Lymphoma (NHL) Patients
Condition: Non-Hodgkin's Lymphoma |
| 37. | | Recruiting | A Study of Rituximab versus Iodine I 131 Tositumomab Therapy for Patients with Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma |
| 38. | | Recruiting | Gemcitabine, Carboplatin, and Dexamethasone With or Without Rituximab in Treating Patients With Relapsed or Primary Refractory Lymphoma
Conditions: Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; Cutaneous T-Cell Lymphoma; ... |
| 39. | | Recruiting | Giving Gene Marked Epstein Barr Virus (EBV) Specific T-Cells to Patients Receiving a Bone Marrow Transplant (BMT) for Relapsed EBV-Positive Hodgkin Disease
Conditions: Hodgkin Disease; Non-Hodgkins Lymphoma |
| 40. | | Recruiting | Giving Gene Marked (Optional) Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Patients with Relapsed EBV-Positive Lymphoma,
Conditions: Hodgkins Disease; Non-Hodgkins Lymphoma |
| 41. | | Recruiting | Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma |
| 42. | | Not yet recruiting | Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma
Condition: Non-Hodgkins Lymphoma |
| 43. | | Recruiting | Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
Conditions: adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; Non-Hodgkin's Lymphoma |
| 44. | | Recruiting | Phase II study of ONTAK in previously treated patients with low-grade Non-Hodgkin's Lymphoma (NHL)
Conditions: Non-Hodgkin's Lymphoma; Lymphoma, B-Cell; Lymphoma, Low-Grade |
| 45. | | Recruiting | A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.
Condition: Non-Hodgkin's Lymphoma |
| 46. | | Recruiting | Megadose CD34 Selected Progenitor Cells for Transplantation in Patients with Advanced Hematological Malignant Diseases
Conditions: Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia; Non Hodgkin's Lymphoma |
| 47. | | Recruiting | Safety and Efficacy of Campath in Nonmyeloablative Transplantation
Conditions: Non Hodgkin's Lymphoma; Hodgkin's Disease; Chronic Lymphocytic Leukemia |
| 48. | | Recruiting | Lower-Dose Chemotherapy and Stem Cell Transplantation to Treat Childhood Leukemias and Lymphomas
Conditions: Hodgkin Lymphoma; Lymphocytic Leukemia; Mixed Cell Leukemia; Myelodysplastic Syndrome; Non Hodgkin's Lymphoma |
| 49. | | Recruiting | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Conditions: Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; Non-Hodgkin's Lymphoma |
| 50. | | Recruiting | EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients with AIDS-Associated Lymphoma
Conditions: AIDS Related Lymphoma; Non Hodgkin's Lymphoma |
